Defence Therapeutics's total assets for Q3 2024 were C$968.28K, an increase of 44.77% from the previous quarter. DTCFF total liabilities were C$3.27M for the fiscal quarter, a 10.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.